Phase I single-dose trial of KPI 10 in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 12 Sep 2012
At a glance
- Drugs KPI 10 (Primary)
- Indications Bacterial infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Kalidex Pharmaceuticals
- 12 Sep 2012 Status changed from active, no longer recruiting to completed, based on results presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapeutics (ICAAC)
- 11 Sep 2012 New trial record
- 07 Sep 2012 Results were presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).